Radioimmunotherapy with (131)I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL). [electronic resource]
Producer: 20110909Description: 136-45 p. digitalISSN:- 1743-7563
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Disease-Free Survival
- Female
- Humans
- Iodine Radioisotopes -- therapeutic use
- Kaplan-Meier Estimate
- Lymphoma, B-Cell -- mortality
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- mortality
- Radioimmunotherapy -- methods
- Rituximab
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.